Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis
about
Replacement of interleukin-2 (IL-2)-generated mitogenic signals by a mink cell focus-forming (MCF) or xenotropic virus-induced IL-9-dependent autocrine loop: implications for MCF virus-induced leukemogenesisAppearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesisDisruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.Characterization of a novel murine retrovirus mixture that facilitates hematopoiesisRecombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomasA transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genesA multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.Moloney murine leukemia virus activates NF-kappa BDiminished potential for B-lymphoid differentiation after murine leukemia virus infection in vivo and in EML hematopoietic progenitor cells.Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeatA population of murine hematopoietic progenitors expresses an endogenous retroviral gp70 linked to the Rmcf gene and associated with resistance to erythroleukemiaExpression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia virusesIncreased hematopoiesis in mice soon after infection by Friend murine leukemia virus.Long-range mapping of Mis-2, a common provirus integration site identified in murine leukemia virus-induced thymomas and located 160 kilobase pairs downstream of Myb.Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.Preleukemic hematopoietic hyperplasia induced by Moloney murine leukemia virus is an indirect consequence of viral infection.Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic miceT-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implicationsRecombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the virusesSplenic accumulation of interleukin-3-dependent hematopoietic cells in Friend erythroleukemia.Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological propertiesIdentification of LTR-specific small non-coding RNA in FeLV infected cells.Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.Infection by mink cell focus-forming viruses confers interleukin 2 (IL-2) independence to an IL-2-dependent rat T-cell lymphoma line.APOBECs and virus restriction.Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.Moloney murine leukemia virus-induced tumors show altered levels of proapoptotic and antiapoptotic proteins.Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus.Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene.Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivoSpecific in vivo expression in type II pneumocytes of the Jaagsiekte sheep retrovirus long terminal repeat in transgenic mice.
P2860
Q28564700-527CE3C2-64D0-4D8B-84F7-6818519C18C4Q33815467-39B27864-FC23-4EE3-A71D-7B7D3F68EC15Q34332095-9FC509F3-0CAC-4A60-A69A-3402646B872AQ34358833-34A04E66-A054-45A4-9DAD-19A0871D29ABQ35832302-5ABD27A8-B3BE-4150-AB20-7BD8D1F791CFQ35845275-6EF66EC4-15B2-443E-A9D3-4013BAEF2A64Q35850989-AE029391-223D-4B0E-842E-FEDB4CC33C64Q35861712-AF309E80-C570-4C13-9D4F-775D5A804848Q35862437-5B545E21-6931-4D23-B0D5-C55A79BA8553Q35914419-37F30D49-038F-480C-84A8-8D38F63B83E4Q36230303-7994CAC7-F458-4120-9870-C7B4841275C9Q36356254-B66DAE1D-22C0-4702-9485-1BFF4239AB28Q36477179-70C7618E-4A9B-4858-8EEC-F345DDC087CEQ36634291-B33F75DF-2AED-4445-AD7F-40465664A341Q36649211-9C027790-D582-4B17-82FD-F0439DF3854AQ36652861-1BBE1F1C-8B5E-441C-A385-8F8D0268871DQ36655037-F78C7ADA-E358-4473-80C6-216FBF633C40Q36783374-82894EFB-0919-4D7A-BB40-8F7F556A6634Q36798128-1A827789-B29F-45EB-A88F-072CE86BAA06Q36812061-94A6C413-AD1D-4C6E-A229-E2B9A6D78592Q36812574-308A493A-B82B-46D9-817A-4D8AC0E65BABQ36827935-F11A4855-8610-4B5C-9F7F-BD98D1E5F285Q36831242-198F0EFB-6637-440E-92B0-068912FEF677Q36871966-349DA730-B90C-427F-A71D-3EBF94253257Q37176304-3810478B-D774-4114-9156-F1BFDB0A98B5Q37256742-AFA26C6E-FF70-4CD0-AE38-85E11EE5F1FFQ37433347-1594795F-79F5-489C-A32F-0361C0DC3454Q37518492-657BC214-E506-4400-B8FE-CF0096E8D951Q38394187-F5E54404-A8DB-4CDF-9DD1-373E530E5E37Q39551987-364B7C24-C167-419D-886D-368D890E7BECQ39593123-C947585F-6ACC-49A7-9077-ABB81B98A1C8Q39868453-FD5DC0DB-BCA7-4F46-ABDD-F2CBF4D7289EQ39875687-D461705C-1740-4715-A951-7D35725CDCB7Q40106399-407C7192-8396-4B04-B7C6-C51C8B1EEC7AQ41898979-7EE401D5-C0FD-4405-BEB8-89072412931FQ41981904-B465A3CC-AA2F-4F05-9873-3AC0B78BECCAQ43152208-E64C39EB-2017-42D5-95EC-2E973B8FA2F9
P2860
Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis
description
1987 nî lūn-bûn
@nan
1987 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Characterization of a preleuke ...... n events during leukemogenesis
@ast
Characterization of a preleuke ...... n events during leukemogenesis
@en
Characterization of a preleuke ...... n events during leukemogenesis
@nl
type
label
Characterization of a preleuke ...... n events during leukemogenesis
@ast
Characterization of a preleuke ...... n events during leukemogenesis
@en
Characterization of a preleuke ...... n events during leukemogenesis
@nl
prefLabel
Characterization of a preleuke ...... n events during leukemogenesis
@ast
Characterization of a preleuke ...... n events during leukemogenesis
@en
Characterization of a preleuke ...... n events during leukemogenesis
@nl
P2093
P2860
P356
P1476
Characterization of a preleuke ...... n events during leukemogenesis
@en
P2093
P2860
P304
P356
10.1073/PNAS.84.14.4875
P407
P577
1987-07-01T00:00:00Z